You are here: Industry Insights > Sinopharm

News List

Pakistan grants EUA to Sinopharm’s Covid-19 vaccine pharmaceutical-technology
January 19, 2021
The Drug Regulatory Authority of Pakistan (DRAP) has granted emergency use authorisation (EUA) to China National Pharmaceutical Group’s (Sinopharm) Covid-19 vaccine.
China grants conditional market approval for Sinopharm CNBG's COVID-19 vaccine worldpharmanews
January 06, 2021
The inactivated COVID-19 vaccine developed by Beijing Institute of Biological Products of Sinopharm CNBG has been granted conditional registration by the NMPA of China, Chinese equivalent of FDA, according to a press conference of the ...
Bahrain approves Sinopharm’s Covid-19 vaccine registration pharmaceutical-technology
December 15, 2020
The Bahrain National Health Regulatory Authority (NHRA) has approved the registration of the Covid-19 vaccine by Chinese company Sinopharm.
China’s Sinopharm says coronavirus vaccine could be ready by year-end – state media expresspharma
July 24, 2020
Sinopharm Chairman Liu Jingzhen told state broadcaster CCTV the company expects to finish late-stage human testing within about three months.
China’s indigenously developed COVID-19 vaccines set to surprise the world: GlobalData expresspharma
July 21, 2020
China's Sinopharm and Sinovac (in collaboration with Brazil-based Butantan) have both reported encouraging results in the early phases of human testing for COVID-19.
China’s Sinopharm begins late stage trial of COVID-19 vaccine in UAE expresspharma
July 20, 2020
The human trial is a partnership between Sinopharm’s China National Biotec Group (CNBG), Abu Dhabi-based artificial intelligence and cloud computing company Group 42 (G42) and the Abu Dhabi Department of Health.
Sinopharm demonstrates king size growth, yet again biospectrumasia
October 23, 2018
Sinopharm, a dominant name in the distribution of pharmaceutical and healthcare products in China, continues to grab a l

Previous page 1 2 Next page